Mobile

Multinational Clinical Trial of 12 weeks of duration to test the efficacy and safety of a new drug called CHF 1535 200/6µg (fixed combination beclomethasone dipropionate / formoterol) versus beclomet...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020602-14

Multinational Clinical Trial of 12 weeks of duration to test the efficacy and safety of a new drug called CHF 1535 200/6µg (fixed combination beclomethasone dipropionate / formoterol) versus beclomethasone dipropionate in adults asthmatic patients not adequately controlled on high doses of inhaled corticosteroids or on medium dose of inhaled corticosteroids plus long-acting β2 agonists

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To show the superiority of CHF 1535 (BDP/FF) pMDI (800/24µg per day) over BDP HFA (Qvar®) pMDI (800µg per day) in terms of lung function considering change from baseline to the entire treatment period in average pre-dose morning PEF in adult asthmatic patients not adequately controlled on high doses of ICS or on medium dose of ICS+LABA.

Critère d'inclusion

  • ADULTS ASTHMATIC PATIENTS NOT ADEQUATELY CONTROLLED ON HIGH DOSES OF INHALED CORTICOSTEROIDS OR ON MEDIUM DOSE OF INHALED CORTICOSTEROIDS PLUS LONG-ACTING β2 AGONISTS

Liens